BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 23189836)

  • 1. [The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection].
    Feng X; Yan HP; Liao HY; Liu YM; Zhang GY; Lin F; Zhao Y; Huang YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):253-5. PubMed ID: 23189836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
    Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
    Tsai SL; Chen PJ; Lai MY; Yang PM; Sung JL; Huang JH; Hwang LH; Chang TH; Chen DS
    J Clin Invest; 1992 Jan; 89(1):87-96. PubMed ID: 1729285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
    Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
    J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
    J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
    Zhang XD; Ren S; Yu HB; Liu YL; Jin Y; Huang YX; Chen JM; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):674-7. PubMed ID: 22152382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral and cellular immune responses to HBV in the blood donors].
    Yang YL; Huang ZH; Cai XB; Cai J; Ma GM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):404-6. PubMed ID: 22482413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
    Duan XZ; He HX; Zhuang H
    J Gastroenterol Hepatol; 2006 Jun; 21(6):970-6. PubMed ID: 16724980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients.
    Dammermann W; Bentzien F; Stiel EM; Kühne C; Ullrich S; Schulze Zur Wiesch J; Lüth S
    J Transl Med; 2015 May; 13():157. PubMed ID: 25968473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
    Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
    J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
    Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
    Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
    J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
    Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
    J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.